Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the maintenance effect and safety of 20 mg
tasimelteon versus placebo in subjects suffering from Non-24-Hour Sleep-Wake Disorder.